Globe Newswire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint Jun 3, 2024 12:21PM

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and reminds investors of the June 4, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson... (continue reading...)

Kirby McInerney LLP Reminds Lincoln National Corporation (LNC) Investors of Class Action Filing and Encourages Investors to Contact the Firm Jun 3, 2024 12:16PM

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Lincoln National Corporation (“Lincoln National” or the “Company”) (NYSE: LNC) securities during the period of November 4, 2020 to November 2, 2022, inclusive (“the Class Period”). Investors have until June 24, 2024 to... (continue reading...)

Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies Jun 3, 2024 12:15PM  Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies

 

 

• New analyses of ACTISAVE phase 2/3 study show positive trends for glenzocimab in subpopulations of patients
• Continuation of clinical studies: Phase 2/3 GREEN in Ischemic stroke and Phase 2b LIBERATE in myocardial infarction
• Launch of GALICE, a Phase 2/3 study in severe ischemic stroke, sponsored by the Hôpital Fondation Adolphe de Rothschild... (continue reading...)

BGHL (GBP): Estimated NAV(s) Jun 3, 2024 12:15PM

BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 31/05/2024.

Estimated NAV

 Euro SharesSterling SharesEstimated NAV€    28.0039£    25.1034Estimated MTD return     1.15 %     1.24 %Estimated YTD return     1.65 %     2.17 %Estimated ITD return   180.04 %   151.03 %

NAV and returns are calculated... (continue reading...)

BGHL (EUR): Estimated NAV(s) Jun 3, 2024 12:15PM

BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 31/05/2024.

Estimated NAV

 Euro SharesSterling SharesEstimated NAV€    28.0039£    25.1034Estimated MTD return     1.15 %     1.24 %Estimated YTD return     1.65 %     2.17 %Estimated ITD return   180.04 %   151.03 %

NAV and returns are calculated... (continue reading...)